MARY WADE: Open Payments
NPI 1689687824 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,070 in 11 payments from 9 companies in 2025. Trend: 2023 $1,837 · 2024 $983 · 2025 $1,070
Food & beverage: $1,070
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $265 |
| Amgen Inc. | 1 | $148 |
| Novo Nordisk Inc | 1 | $122 |
| Teva Pharmaceuticals USA, Inc. | 1 | $118 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $118 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $98 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $96 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $86 |
| Alkermes, Inc. | 1 | $19 |
Products named: Auvelity, AUSTEDO XR, Kerendia, Tryvio, ARISTADA.
Industry payments across AL — which companies pay providers there.
